574: Efficacy of hydralazine, labetalol, and nifedipine for the acute reduction of severe hypertension in pregnancy: a systematic review

2015 ◽  
Vol 212 (1) ◽  
pp. S286-S287 ◽  
Author(s):  
Brad Holbrook ◽  
Pranita Nirgudkar ◽  
Ellen Mozurkewich
Keyword(s):  
Systematic Review ◽  
Severe Hypertension ◽  
Hypertension In Pregnancy ◽  
In Pregnancy

First-line antihypertensive treatment for severe hypertension in pregnancy: A systematic review and network meta-analysis

2019 ◽  
Vol 18 ◽  
pp. 179-187 ◽  
Author(s):  
Sepand Alavifard ◽  
Rebecca Chase ◽  
Ghayath Janoudi ◽  
Andréanne Chaumont ◽  
Andrea Lanes ◽  
...  
Keyword(s):  
Systematic Review ◽  
Antihypertensive Treatment ◽  
Severe Hypertension ◽  
Meta Analysis ◽  
First Line ◽  
Hypertension In Pregnancy ◽  
In Pregnancy

scholarly journals Tailored physiologic treatment of severe hypertension in pregnancy: a novel approach to hypertension management

2022 ◽  
Vol 226 (1) ◽  
pp. S282
Author(s):  
Allison M. Davis ◽  
Christina T. Blanchard ◽  
Akila Subramaniam ◽  
Rachel G. Sinkey ◽  
Alan T. Tita ◽  
...  
Keyword(s):  
Severe Hypertension ◽  
Hypertension Management ◽  
Hypertension In Pregnancy ◽  
Novel Approach ◽  
In Pregnancy

scholarly journals Hypertension in pregnancy: Pathophysiology and treatment

2019 ◽  
Vol 7 ◽  
pp. 205031211984370 ◽  
Author(s):  
Stephanie Braunthal ◽  
Andrei Brateanu
Keyword(s):  
Gestational Hypertension ◽  
Severe Hypertension ◽  
Organ Damage ◽  
Morbidity And Mortality ◽  
Perinatal Morbidity ◽  
Hypertensive Disorders Of Pregnancy ◽  
Hypertension In Pregnancy ◽  
Hypertensive Disorders ◽  
In Pregnancy ◽  
The Ideal

Hypertensive disorders of pregnancy, an umbrella term that includes preexisting and gestational hypertension, preeclampsia, and eclampsia, complicate up to 10% of pregnancies and represent a significant cause of maternal and perinatal morbidity and mortality. Despite the differences in guidelines, there appears to be consensus that severe hypertension and non-severe hypertension with evidence of end-organ damage need to be controlled; yet the ideal target ranges below 160/110 mmHg remain a source of debate. This review outlines the definition, pathophysiology, goals of therapy, and treatment agents used in hypertensive disorders of pregnancy.

Sign in / Sign up

Export Citation Format

Share Document